Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.3 USD | -2.13% |
|
+2.60% | -15.99% |
10/07 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
09/07 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.99% | 651.62Cr | |
+63.05% | 86TCr | |
+39.16% | 63TCr | |
-4.78% | 36TCr | |
+17.52% | 32TCr | |
+8.43% | 30TCr | |
+13.57% | 24TCr | |
+5.32% | 23TCr | |
+16.44% | 23TCr | |
+14.63% | 18TCr |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating